Not a good buy right now for an impatient investor: price is extended into/above a key resistance zone (~61.01) ahead of earnings, with statistical pattern signals skewing negative over the next week/month.
No Intellectia “strong buy” triggers today (no AI Stock Picker or SwingMax entry), so there’s no high-conviction timing edge.
Options are priced for a big move (IV percentile ~99), which typically raises the bar for buying shares immediately before a catalyst.
Best stance from this setup: hold/avoid new entry today; only turns attractive after earnings if it holds above ~61 on strong follow-through or pulls back toward ~58 support with stabilization.
Trend/momentum: MACD histogram is positive (0.218) but positively contracting → upside momentum exists but is weakening.
RSI(6) ~54.8 (neutral) → no oversold “easy buy” condition.
Moving averages: converging → suggests consolidation/indecision rather than a clean trend.
Key levels: Pivot 57.997; Resistance R2 61.008. Current price 61.56 is above R2, which can be bullish if it holds, but also increases near-term pullback risk (breakout failure risk).
Quant/pattern read: similar-pattern stats imply ~-7.13% next week and ~-6.47% next month (near-term bias down despite a small next-day drift).
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/sentiment: Open interest put-call ratio 0.15 is call-heavy (bullish positioning).
Activity: very low absolute volume (15 puts, 0 calls today) → sentiment signal is mostly from OI positioning, not fresh flow.
Volatility: 30D IV 56.57 vs historical vol 23.06; IV percentile 99.2 → options are pricing an unusually large move (typical around earnings), which often reduces the attractiveness of chasing shares right now.
Volume anomaly: today’s option volume vs 30D avg ~300% (from a low base), and today vs OI avg ~101.84% → some uptick, but still not broad participation.
Technical Summary
Sell
5
Buy
12
Positive Catalysts
after earnings would confirm a breakout and could trigger follow-through buying.
No analyst rating/price target changes were provided in the dataset, so there’s no observable recent Wall Street trend to confirm a buy thesis.
Wall Street “pros” view (inferred from available data): margin expansion is a pro, but declining revenue/EPS and the pre-earnings uncertainty are notable cons.
Politicians/congress/influentials: no recent congress trading data available; hedge funds and insiders shown as neutral with no significant recent trend.
Wall Street analysts forecast CNXN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNXN is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast CNXN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNXN is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
